Coverage, Formulary Restrictions, and Out-of-Pocket Costs for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Medicare Part D Program

This cross-sectional study assesses drug coverage, formulary restrictions, median retail prices, and annual out-of-pocket costs associated with commonly used insulin products across Medicare Part D plans.

Detalles Bibliográficos
Autores principales: Luo, Jing, Feldman, Robert, Rothenberger, Scott D., Hernandez, Inmaculada, Gellad, Walid F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563069/
https://www.ncbi.nlm.nih.gov/pubmed/33057641
http://dx.doi.org/10.1001/jamanetworkopen.2020.20969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563069/
https://www.ncbi.nlm.nih.gov/pubmed/33057641
http://dx.doi.org/10.1001/jamanetworkopen.2020.20969

Ejemplares similares